Cited by 338Genetic Associations and EpidemiologyLipoproteins and Cardiovascular HealthCardiovascular Health and Risk Factors

Genomic prediction of coronary heart disease

Open access
Abraham, Gad, Havulinna, Aki S., Bhalala, Oneil G., Byars, Sean G., De Livera, Alysha M., Yetukuri, Laxman, Tikkanen, Emmi, Perola, Markus +7 more·2016·European Heart Journal

Published version of a preprint

Abstract

AIMS: Genetics plays an important role in coronary heart disease (CHD) but the clinical utility of genomic risk scores (GRSs) relative to clinical risk scores, such as the Framingham Risk Score (FRS), is unclear. Our aim was to construct and externally validate a CHD GRS, in terms of lifetime CHD risk and relative to traditional clinical risk scores. METHODS AND RESULTS: We generated a GRS of 49 310 SNPs based on a CARDIoGRAMplusC4D Consortium meta-analysis of CHD, then independently tested it using five prospective population cohorts (three FINRISK cohorts, combined n = 12 676, 757 incident CHD events; two Framingham Heart Study cohorts (FHS), combined n = 3406, 587 incident CHD events). The GRS was associated with incident CHD (FINRISK HR = 1.74, 95% confidence interval (CI) 1.61-1.86 per S.D. of GRS; Framingham HR = 1.28, 95% CI 1.18-1.38), and was largely unchanged by adjustment for known risk factors, including family history. Integration of the GRS with the FRS or ACC/AHA13 scores improved the 10 years risk prediction (meta-analysis C-index: +1.5-1.6%, P < 0.001), particularly for individuals ≥60 years old (meta-analysis C-index: +4.6-5.1%, P < 0.001). Importantly, the GRS captured substantially different trajectories of absolute risk, with men in the top 20% of attaining 10% cumulative CHD risk 12-18 y earlier than those in the bottom 20%. High genomic risk was partially compensated for by low systolic blood pressure, low cholesterol level, and non-smoking. CONCLUSIONS: A GRS based on a large number of SNPs improves CHD risk prediction and encodes different trajectories of lifetime risk not captured by traditional clinical risk scores.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehw450

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Abraham, G., Havulinna, A. S., Bhalala, O. G., Byars, S. G., De Livera, A. M., Yetukuri, L., Tikkanen, E., Perola, M., Schunkert, H., Sijbrands, E. J., Palotie, A., Samani, N. J., Salomaa, V., Ripatti, S., & Inouye, M.
Affiliations
  • The University of Melbourne (AU)
  • Finnish Institute for Health and Welfare (FI)
  • University of Helsinki (FI)
  • German Centre for Cardiovascular Research (DE)
  • Erasmus MC (NL)
  • Broad Institute (US)
  • University of Leicester (GB)
Corresponding author
  • Samani, Nilesh J.
  • Salomaa, Veikko
  • Ripatti, Samuli
  • Inouye, Michael
Venue
European Heart Journal
Published
2016-09-21
Volume
37
Issue
43
Pages
3267-3278
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2521147375
Cited by
338
References
39
Citations by year
2026: 11 · 2025: 18 · 2024: 31 · 2023: 31 · 2022: 34 · 2021: 49 · 2020: 44 · 2019: 50 · 2018: 35 · 2017: 25 · 2016: 10
FWCI
5.44
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RMIT Research Repository (RMIT University Library) (submittedVersion, other-oa)
  • Figshare (submittedVersion, cc-by)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
  • Apollo (cc-by)
Funders
  • American Heart Association
  • Foundation for Cardiovascular Research
  • Wellcome Trust (FP7/2007–2013, 085475, R01 HL087676, 076113)
  • Broad Institute
  • National Institute for Health and Care Research (FP7/2007–2013, NF-SI-0611-10170)
  • British Heart Foundation
  • European Commission (2007–2013, FP7 2007-2013, 261433, FP7/2007, 285380)
  • National Heart Foundation of Australia (1061435)
  • Academy of Finland (286500, 285380, 251217)
  • NordForsk (62721)
  • Sydäntutkimussäätiö (62721)
  • National Institutes of Health (FP7/2007-2013)
  • Medical Research Council (MR/N01104X/1)
  • National Health and Medical Research Council (1061435, 1090462, 1062227)
  • National Heart, Lung, and Blood Institute (R01HL087676)
  • National Center for Research Resources
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
coronary artery disease, genomic risk score, genetic risk prediction, Framingham risk score, clinical risk score, lifetime cardiovascular risk, single nucleotide polymorphisms, external validation, systolic blood pressure, cholesterol, smoking, older adults
MeSH terms
Coronary Disease, Female, Heart Diseases, Humans, Male, Risk Factors, Risk Assessment, Polymorphism, Single Nucleotide, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review